Browsing: Ebola

Last week, the government of the Democratic Republic of the Congo (DRC) requested a release of Ervebo vaccines from the global Ebola virus disease vaccine stockpile, managed by the International Coordinating Group on Vaccine Provision (ICG). The request was for use of the vaccine in the current Bundibugyo virus disease outbreak. Ervebo vaccine is licensed…

Oslo, 20 August 2026:  CEPI is providing US$4.17 million to four research projects designed to assess whether vaccines already or previously licensed against Zaire ebolavirus—including Ervebo—could offer protection against Bundibugyo ebolavirus, the virus behind the rapidly escalating outbreak in the Democratic Republic of the Congo, which was declared a Public Health Emergency of International Concern…

The Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo is in a phase of intense transmission. It is the largest Ebola outbreak ever reported in the country and expanding faster than any previous Ebola outbreak. The epidemic is increasingly characterized by sustained transmission within interconnected geographic clusters. Initially confined to the…